rituximab (Q412323)

From Wikidata
Jump to navigation Jump to search
pharmaceutical drug
  • IDEC-102
  • RG-105
  • IDEC-C2B8
  • AntiCD20
  • R-105 IDEC-102
  • Ig gamma-1 chain C region
  • Rituxan
  • Mabthera
edit
Language Label Description Also known as
English
rituximab
pharmaceutical drug
  • IDEC-102
  • RG-105
  • IDEC-C2B8
  • AntiCD20
  • R-105 IDEC-102
  • Ig gamma-1 chain C region
  • Rituxan
  • Mabthera

Statements

1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
0 references
Rituximab
0 references

Identifiers

0 references
1 reference
28 October 2019
RITUXIMAB (English)
10 May 2021
0 references
695-706-4
1 reference
27 December 2018
Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal IDEC-C2B8 .gamma.1-chain), disulfide with human-mouse monoclonal IDEC-C2B8 .kappa.-chain, dimer (English)
CAS no.: 174722-31-7 (English)
1 reference
27 December 2018
Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal IDEC-C2B8 .gamma.1-chain), disulfide with human-mouse monoclonal IDEC-C2B8 .kappa.-chain, dimer (English)
CAS no.: 174722-31-7 (English)
0 references
0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit